Vinu Krishnan's dissertation on drug delivery has earned recognition from the American Association for Cancer Research.

Research recognition

UD doctoral student's drug delivery dissertation earns recognition

TEXT SIZE

1:07 p.m., March 5, 2013--How does the idiom go? What you don’t know won’t hurt you?

Vinu Krishnan, a University of Delaware doctoral student thinks, “What you can’t see may actually help you.”

Research Stories

Battling RRD

UD's Tom Evans is part of a research group that has been awarded $4.6 million by the U.S. Department of Agriculture to study methods to combat rose rosette disease.

Oct. 30: Nobel Symposium

UD faculty members with expertise in the areas that won 2014 Nobel Prizes will discuss the laureates' work on Oct. 30.

Krishnan is studying nanotechnology-based drug delivery under the supervision of A.K. Rajasekaran, adjunct professor of materials science and engineering at UD, and director of basic cancer research program at the Nemours/A.I. duPont Hospital for Children, and Xinqiao Jia, UD associate professor of materials science and engineering and biomedical engineering.

It is work conducted at the nanoscale, sizes smaller than a human hair.

The team is working together to help reduce chemotherapy-induced side effects in children fighting acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. 

“Although existing treatment procedures with chemotherapy have achieved five-year survival rates of 90 percent in children affected with ALL, more than 60 percent of patients either succumb to, or live the remainder of their lives with side effects,” Krishnan explained. 

The research group has shown that the most commonly used leukemia fighting drug, Dexamethasone, can be successfully encapsulated in nanoparticles and used to treat leukemia. The study revealed that this approach improved survival and reduced disease symptoms in preclinical models. 

Krishnan’s dissertation, which is a continuation of Rajasekaran and Jia’s promising nanotechnology work, earned him the Gerald B. Grindey Memorial Scholar-in-Training Award from the American Association for Cancer Research (AACR).

Given annually, the award recognizes a scholar with the most “meritorious pre-clinical cancer research paper in the field.”

Krishnan credits Rajasekaran and Jia with helping him “achieve a noble purpose in life.” 

“This award enables me to chart out my career ahead — especially in terms of deciding whether to work in academia or industry,” he concluded.

“I am very proud of Vinu and the team members who worked tirelessly on this study. Our next step is to validate this approach for future clinical trials and bring this to the bedside to treat children with cancer,” said Rajasekaran.

Krishnan will present his paper, titled “Nanotechnology Based Drug Delivery in Childhood Leukemia Therapy: A Novel Approach to Reduce Side Effects,” at the AACR poster presentation in Washington, D.C., April 6-10. 

About project support

The work is supported by the National Institutes of Health (RO1 DK56216, P20RR016458, P20 RR017716), Delaware Health Sciences Alliance, Andrew McDonough B+ Foundation, Caitlin Robb Foundation, Kids Runway for Research, Sones Brothers, Nemours Foundation and the University of Delaware.

Article by Gregory Holt

Photo by Kathy F. Atkinson

icon-fb icon-tw icon-yt icon-fs
ADVERTISEMENT

News Media Contact

University of Delaware
Office of Communications & Marketing
302-831-NEWS
ud-ocm@udel.edu

UDaily is produced by the
Office of Communications & Marketing

The Academy Building
105 East Main Street
University of Delaware
Newark, DE 19716 | USA
Phone: (302) 831-2792
email: ud-ocm@udel.edu
www.udel.edu/ocm
University of Delaware • Newark, DE 19716
ud-ocm@udel.edu • (302) 831-2792 • ©2012
University of Delaware • Newark, DE 19716 • USA • Phone: (302) 831-2792 • © 2013
Comments|Contact Us|Legal Notices